• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconEli Lilly

Eli Lilly

Page 6 of 7
General Views of Eli Lilly & Co.
NewslettersEli Lilly is teaching an old drug technology new tricks against COVID—and has promising early results
By Sy MukherjeeSeptember 17, 2020
Eli Lilly Earnings Diabetes Sales
NewslettersEli Lilly smashed Wall Street projections thanks to its diabetes drugs
By Sy MukherjeeJanuary 30, 2020
3 Drug Giants Win a Legal Victory Against Trump—For Now: Brainstorm Health
Health3 Drug Giants Win a Legal Victory Against Trump—For Now: Brainstorm Health
By Sy MukherjeeJuly 9, 2019
Drug price TV ad lawsuit
HealthBig Drug Makers Sue to Block Mandatory Price Disclosures in TV Ads: Brainstorm Health
By Sy MukherjeeJune 14, 2019
Migraine, Illustration
HealthThe FDA Just Approved a Third Migraine Drug—and It’s Free (At Least for Now)
By Lucas LaursenSeptember 28, 2018
Alzheimers-dementia-brain-research
HealthEli Lilly, AstraZeneca’s Alzheimer’s Drug Flop Is the Latest Disappointment in a Frustrating Disease
By Sy MukherjeeJune 12, 2018
U.S. Multinationals in Puerto Rico
HealthEli Lilly CEO Welcomes Amazon’s Arrival in the Health Care Business
By David MeyerJanuary 31, 2018
COLOMBIA-YARUMAL-ALZHEIMER
HealthAlzheimer’s Cases Are Expected to Double By 2060 and We’re Not Ready for It
By Sy MukherjeeDecember 7, 2017
BioGen Alzheimers
HealthWe’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?
By Sy MukherjeeNovember 2, 2017
BioGen Alzheimers
HealthCould a New Immunotherapy Medical Approach Break the Alzheimer’s Drug Curse?
By Sy MukherjeeOctober 24, 2017
Man walks downstairs
HealthBig Pharma Just Had a Terrible, Horrible, No Good, Very Bad Week of Job Cuts
By Sy MukherjeeDecember 12, 2016
Mobile World Congress - Day 1
TechMicrosoft Gets Backup in Its Fight Against U.S. Government Gag Orders
By Barb DarrowSeptember 6, 2016
Eli Lilly & Co Chief Executive Officer John Lechleiter Interview
HealthEli Lilly to Continue Breakthrough Breast Cancer Drug Trial Despite Failed Test
By ReutersAugust 11, 2016
Eli Lilly & Co Chief Executive Officer John Lechleiter Interview
HealthEli Lilly’s CEO John Lechleiter Is Retiring at the End of the Year
By ReutersJuly 27, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthThese Are the Most Promising Experimental Cancer Drugs
By Sy MukherjeeJune 9, 2016
1...
  • 3
  • 4
  • 5
  • 6
  • 7
7
Most Popular
Success
Scottie Scheffler joined Tiger Woods and Rory McIlroy in golf's $100M club—and donated his entire Ryder Cup stipend to charityplaceholder alt text
By Fortune EditorsApril 10, 2026
Politics
The Navy confirmed an ‘abundant amount’ of Uncrustables when the Artemis II crew lands. Smucker’s just offered them a lifetime supplyplaceholder alt text
By Fortune EditorsApril 10, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.